Article
Surveillance imaging frequency in adult patients with lower-grade (WHO Grade 2 and 3) gliomas.
Neuro-oncology - 1 Jul 2022
Jo Jasmin, van den Bent Martin J, Nabors Burt, Wen Patrick Y, Schiff David
Abstract excerpt
With improved outcome following aggressive treatment in patients with grade 2 and 3 IDH-mutant (IDHmt), 1p/19q codeleted oligodendroglioma and IDHmt, non-codeleted astrocytoma, prolonged surveillance is desirable for early detection of tumor growth and malignant transformation. Current National Comprehensive Cancer Network (NCCN) guidelines provide imaging follow-up recommendations based on molecular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
